Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

Acta Oncologica

Volumn 51, Issue 6, 2012, Pages 722-729

  Dieperink, Karin B ^a   Hansen, Steinbjørn ^a   Wagner, Lis ^b   Johansen, Christoffer ^c   Andersen, Klaus K ^c   Hansen, Olfred ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORBIDITY; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 12; SMOKING; URINE INCONTINENCE;

AGED; ANDROGENS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; INDEPENDENT LIVING; MALE; MARITAL STATUS; MIDDLE AGED; OBESITY; PROGNOSIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84863863123     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.682627     Document Type: Article

References (25)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
2. Cancerregisteret 2009. Copenhagen: Sundhedsstyrelsen; 2010. Available from: http://www.sst.dk [cited 2011 Oct 25].
3. Harmenberg U, Hamdy FC, Widmark A, Lennernas B, Nilsson S. Curative radiation therapy in prostate cancer. Acta Oncol 2011;50(Suppl 1):98-103.
4. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial. Lancet 2009;373:301-8.
5. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358-67. (Pubitemid 39406169)
6. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin 2008;58:196-213.
7. Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 2010;28:5038-45.
8. Dalton SO, Laursen TM, Ross L, Mortensen PB, Johansen C. Risk for hospitalization with depression after a cancer diagnosis: A nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol 2009;27:1440-5.
9. Pardo Y, Guedea F, Aguilo F, Fernandez P, Macias V, Marino A, et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol 2010;28:4687-96.
10. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. New Engl J Med 2008;358:1250-61. (Pubitemid 351439226)
11. Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33. (Pubitemid 126433231)
12. Wei J, Dunn R, Litwin M, Sandler H, Sanda M. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
13. Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology 2010;76:1245-50.
14. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 2003;41:582-92.
15. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557-66. (Pubitemid 34072540)
16. Christensen AI, Davidsen M, Ekholm O, Hansen SE, Holst M, Juel K. Den nationale sundhedsprofil 2010 - hvordan har du det? Copenhagen: Sundhedsstyrelsen; 2011.
17. Wedlake LJ, Thomas K, Lalji A, Blake P, Khoo VS, Tait D, et al. Predicting late effects of pelvic radiotherapy: Is there a better approach? Int J Radiat Oncol Biol Phys 2010;78:1163-70.
18. Alsadius D, Hedelin M, Johansson KA, Pettersson N, Wilderang U, Lundstedt D, et al. Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol 2011;101:495-501.
19. Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis. J Cancer Surviv 2010;4;128-39.
20. Danmarks Statistik [Internet]. [cited 2011 Oct 25]. Copenhagen: Statistics Denmark; 2011. Available from: http://www.dst.dk.
21. Wallace M, Storms S. The needs of men with prostate cancer: Result of a focus group study. Appl Nurs Res 2007;20:181-7.
22. Kazer MW, Harden J, Burke M, Sanda MG, Hardy J, Bailey DE. The experiences of unpartnered men with prostate cancer: A qualitative analysis. J Cancer Surviv 2011;5: 132-41.
23. Johansen C. Rehabilitation of cancer patients - research perspectives. Acta Oncol 2007;46:441-5. (Pubitemid 46752262)
24. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. J Clin Oncol 2010;28:340-7.
25. Rottmann N, Dalton SO, Bidstrup PE, Würtzen H, Høybye MT, Ross L, et al. No improvement in distress and quality of life following psychosocial cancer rehabilitation. A randomised trial. Psychooncology 2012;21:505-14.